EGFR and lung cancer: Although further studies are needed to assess this hypothesis, the in vitro DTP features of TKI‐induced ROS upregulation described above have also been observed in residual tumor tissue specimens from in vivo mouse models of EGFR+ lung cancer after EGFR‐TKI treatment [27].